The market may see some consolidation, but overall, the mood remains bullish. Below are some short-term trading ideas to consider.
The trend is likely to be upward despite consolidation (if any), as frontline indices now trade above all key moving averages. Below are some short-term trading ideas to consider.
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2990 in its research report dated August 01, 2025.
Stocks to Watch Today, 1 August: Stocks like Coal India, Shanti Gold International, Swiggy, PB Fintech, Chalet Hotels, RR Kabel, JSW Energy, Aarti Industries, ITC, Eicher Motors, and Gujarat Gas will be in focus on August 1.
About 1510 shares advanced, 2341 shares declined, and 150 shares were unchanged.
In FY25 alone, the cash pile increased by over Rs 10,200 crore, underscoring a decisive shift in the capital allocation priorities of India’s drugmakers
Motilal Oswal is bullish on Mankind Pharma recommended buy rating on the stock with a target price of Rs 2910 in its research report dated May 22, 2025.
Stocks to Watch, 22 May: Stocks like NBCC (India), Jindal Poly Films,Hindustan Zinc,Data Patterns (India), Zinka Logistics Solutions, KPR Mill, Aarti Industries, Birlasoft, Hindustan Copper, Gallantt Ispat, Geojit Financial Services, Teamlease Services, Mankind Pharma, Astral, GMM Pfaudler, Rail Vikas Nigam, IRCON International, VA Tech Wabag, and Oil India will be in focus on May 22.
Angel One shares closed at Rs 2,328.50, down 0.23 percent, while Nuvama Wealth Management stock rose 1.25 percent to Rs 5,944.
Stocks To Watch, Mar 3: Stocks like Foseco India, Rana Sugars, Maruti Suzuki India, Hyundai Motor India, Eicher Motors, Escorts Kubota, SML Isuzu, Atul Auto, VST Tillers, Dr Agarwals Health Care, Bajaj Auto, Indian Overseas Bank, Voltas, Mankind Pharma, Ujjivan Small Finance Bank, Dalmia Bharat, and Tata Communications will be in focus on March 3.
The Share Purchase Agreement will be executed soon, said Mankind Pharma, and the transaction will be completed by February 28, 2025. Mahananda Spa had a turnover of Rs 74.33 crore in FY24, and a networth of Rs 401.35 crore.
As long as the market defends the midline of Bollinger Bands, the trend may remain in favour of bulls despite Monday's profit booking. Below are some trading ideas for the near term.
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its research report dated January 25, 2025.
Mankind Pharma's Q3 net profit was impacted by the $1.6 billion acquisition of Bharat Serums and Vaccines (BSV), which came into effect from October.
Stocks to Watch, Jan 24: Stocks like Adani Green Energy, KFin Technologies, Mphasis, Mankind Pharma, Suryoday Small Finance Bank, Tejas Networks, Capri Global Capital, Ujjivan Small Finance Bank, Hindustan Petroleum Corporation, Nippon Life India Asset Management, Indian Energy Exchange, and Spandana Sphoorty Financial will be in focus on January 24.
Mankind said the $1.6 billion acquisition of Bharat Serums and Vaccines, effective October, impacted the quarterly results
Macquarie has lowered its FY25/26/27 earnings estimates by 17 percent, 24 percent, and 17 percent, respectively, due to earnings dilution stemming from the BSV acquisition.
Stocks To Watch Today, Jan 8: Stocks like Tata Steel, Dr Reddy’s Laboratories, WPIL, Rail Vikas Nigam, Mahindra and Mahindra, Mankind Pharma, CESC, Birlasoft, Puravankara, Maruti Suzuki India, Orissa Minerals Development Company, State Bank of India, Jindal Worldwide, and Leo Dryfruits & Spices Trading will be in focus on January 8.